It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

Wall Street analysts can barely keep up with the pace of the diabetes and weight ... for Amgen's new weight loss drug, MariTide (formerly AMG133), its injectable obesity drug.

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

(Ivanhoe Newswire) — A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose weight. While these drugs are becoming wildly ...

Shortages will affect non-pen injectable insulins through ... an explanation for what caused the holdup. Diabetes medication shortages are nothing new. The most recent example concerns NovoNordisk’s ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

The high price and side effects of Ozempic, the blockbuster diabetes drug also used off label for ... is a once-a-week injectable medication in the class of GLP-1 receptor agonists used to lower ...

ORLANDO, Fla. (Ivanhoe Newswire) - A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose weight. While these drugs are becoming ...